Wendy R. Brewster, MD, PhD, a compassionate clinician-scientist who focused her career on caring for women with gynecologic cancer and studying at-risk populations and the disparate mechanisms leading to poor outcomes in endometrial, ovarian, and cervical cancers, died of pancreatic cancer on July 24. She passed surrounded and supported by her family in Houston, where her sister lived.
In addition to publishing out-of-print books in oncology, the Cancer History Project highlights new books on the history of the field.
Richard A. Rettig’s “Cancer Crusade: The Story of the National Cancer Act of 1971” is a peerless book, a comprehensive history of the buildup to and enactment of the landmark law that focused the U.S. government’s efforts to cure cancer.
The Zaporizhzhia nuclear power facility, the largest in Europe, with six reactors, has been under Russian control since March, 4, 2022.
The Cancer History Project’s mission includes publishing books that tell the story of oncology and the shaping of its culture.
The initial foray into genomic sequencing two decades ago has led to the discovery of key driver mutations and spurred drug development, thereby transforming the management of imminently lethal diseases.
By the end of World War I, the use of chemical weapons had resulted in over one million casualties on both sides, including many disabled and wounded. Through a series of unintended events, these chemical weapons set in motion discoveries that led to the development of chemotherapy.
In May 1991, I sat in a law firm conference room in Washington, DC, listening to a pitch from a small group of women who had the idea to launch a political advocacy movement around breast cancer. One of those women was Dr. Susan Love. The person next to me nudged me with her elbow and whispered, “She is famous. She wrote this unbelievable book.”
Susan Love, breast oncologist, founder of the breast cancer advocacy movement, and chief visionary officer of the Dr. Susan Love Foundation for Breast Cancer Research, died July 2.
I have no doubt that our professional associations in cancer research and oncology and our NCI in the U.S. care about the plight of cancer scientists and oncologists who have been displaced due to war or violence in their home countries.
